GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™

GNT Pharma South Korea California

View original content:https://www.prnewswire.co.uk/news-releases/gnt-pharma-reports-significant-improvements-in-stroke-patients-treated-with-its-pioneering-phase-3-drug-nelonemdaz-302328565.html